329 related articles for article (PubMed ID: 35001170)
1. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
3. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
[TBL] [Abstract][Full Text] [Related]
4. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
Hirano S; Udagawa O; Kobayashi Y; Kato A
Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation promotes PML degradation during encephalomyocarditis virus infection.
El McHichi B; Regad T; Maroui MA; Rodriguez MS; Aminev A; Gerbaud S; Escriou N; Dianoux L; Chelbi-Alix MK
J Virol; 2010 Nov; 84(22):11634-45. PubMed ID: 20826694
[TBL] [Abstract][Full Text] [Related]
6. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
7. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
[TBL] [Abstract][Full Text] [Related]
8. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
9. Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
Hirano S; Udagawa O
PLoS One; 2022; 17(5):e0268835. PubMed ID: 35594310
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
[TBL] [Abstract][Full Text] [Related]
11. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
Fasci D; Anania VG; Lill JR; Salvesen GS
Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
[TBL] [Abstract][Full Text] [Related]
12. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway.
Komaravelli N; Ansar M; Garofalo RP; Casola A
Free Radic Biol Med; 2017 Dec; 113():494-504. PubMed ID: 29107745
[TBL] [Abstract][Full Text] [Related]
14. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
[TBL] [Abstract][Full Text] [Related]
15. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
16. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P
Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808
[TBL] [Abstract][Full Text] [Related]
17. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
18. The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stability.
Koidl S; Eisenhardt N; Fatouros C; Droescher M; Chaugule VK; Pichler A
Int J Biochem Cell Biol; 2016 Oct; 79():478-487. PubMed ID: 27343429
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
[TBL] [Abstract][Full Text] [Related]
20. Identification of RNF168 as a PML nuclear body regulator.
Shire K; Wong AI; Tatham MH; Anderson OF; Ripsman D; Gulstene S; Moffat J; Hay RT; Frappier L
J Cell Sci; 2016 Feb; 129(3):580-91. PubMed ID: 26675234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]